Jean-Pierre Garnier
Presidente presso CELLECTIS S.A.
Patrimonio netto: 1 M $ in data 31/12/2024
Profilo
Jean-Pierre Garnier è un uomo d'affari francese che è stato a capo di 14 diverse aziende e attualmente occupa la posizione di presidente non esecutivo di Cellectis SA e di presidente di Carmat SA. Il Dr. Garnier è anche nel consiglio di amministrazione di Radius Health, Inc., Max Planck Institute For Biophysical Chemistry e Carrier Global Corp. e Operating Partner di Advent International LLC. In precedenza è stato presidente di NormOxys, Inc., presidente di Alzheon, Inc., presidente di ABIONYX Pharma SA e presidente di Cerenis Therapeutics, Inc. (una filiale di ABIONYX Pharma SA), presidente di Idorsia Ltd., presidente di Idorsia Pharmaceuticals Ltd., amministratore delegato di GlaxoSmithKline Plc e amministratore delegato di Smithkline Beecham Plc (una filiale di GlaxoSmithKline Plc), presidente di e.Nvizion Communications Group Ltd., direttore di Actelion Ltd., amministratore delegato di Pierre Fabre SA, presidente di Schering-Plough Corp. e consigliere di Quaker Partners Management LP. Il Dr. Garnier ha ricevuto un MBA dall'Università di Stanford e un dottorato e una laurea all'Università Louis Pasteur.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CARRIER GLOBAL CORP.
0.00% | 18/04/2024 | 18 110 ( 0.00% ) | 1 M $ | 31/12/2024 |
CELLECTIS SA
-.--% | 14/02/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
BIOAGE LABS, INC.
-.--% | 25/09/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
Ultime notizie su Jean-Pierre Garnier
Posizioni attive di Jean-Pierre Garnier
Società | Posizione | Inizio |
---|---|---|
CARRIER GLOBAL CORPORATION | Direttore/Membro del Consiglio | 03/04/2020 |
CELLECTIS S.A. | Presidente | 05/11/2020 |
BIOAGE LABS, INC. | Presidente | 20/08/2024 |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Carrier Corp. manufactures air conditioning, heating, and refrigeration equipment. Its products include residential systems, commercial systems, transport refrigeration, and commercial refrigeration. The company was founded by Willis Haviland Carrier on July 17, 1902 and is headquartered in Jupiter, FL. | Direttore/Membro del Consiglio | - |
Advent International LLC
Advent International LLC Investment ManagersFinance Advent International LLC provides risk capital and investments. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jean-Pierre Garnier
Società | Posizione | Fine |
---|---|---|
CARMAT | Presidente | 22/12/2022 |
RADIUS HEALTH, INC. | Direttore/Membro del Consiglio | 15/08/2022 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Presidente | 13/05/2020 |
IDORSIA LTD | Presidente | 13/05/2020 |
░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jean-Pierre Garnier
Stanford University | Masters Business Admin |
Louis Pasteur University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 8 |
---|---|
RENAULT | Consumer Durables |
GSK PLC | Health Technology |
ABIONYX PHARMA | Health Technology |
IDORSIA LTD | Health Technology |
CARMAT | Health Technology |
CARRIER GLOBAL CORPORATION | Producer Manufacturing |
CELLECTIS S.A. | Health Technology |
BIOAGE LABS, INC. | Health Technology |
Aziende private | 17 |
---|---|
United Technologies Corp.
United Technologies Corp. Industrial ConglomeratesProducer Manufacturing United Technologies Corp. engages in the provision of products and services to the building systems and aerospace industries worldwide. It operates through the following business segments: Otis; Carrier; Pratt and Whitney; and Collins Aerospace Systems. The Otis segment designs, manufactures, sells, and installs elevators, escalators, moving walkways, and service. The Carrier segment provides heating, ventilating, air conditioning, and refrigeration solutions. The Pratt and Whitney segment includes aircraft engines for the commercial, military, business jet, and general aviation markets. The Collins Aerospace Systems segment offers technologically advanced aerospace products and aftermarket service solutions for aircraft manufacturers, airlines, regional, business and general aviation markets, military, space and undersea operations. The company was founded in 1934 and is headquartered in Farmington, CT. | Producer Manufacturing |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
e.Nvizion Communications Group Ltd. | Finance |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Health Technology |
Newman's Own Foundation
Newman's Own Foundation Investment Trusts/Mutual FundsMiscellaneous Newman's Own Foundation operates as a charity. The firm turns profits from the sale of Newman''s Own products into charitable donations. The company was founded by Paul L. Newman in 2005 and is headquartered in Farmington, CT. | Miscellaneous |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Alzheon, Inc.
Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Max Planck Florida Institute for Neuroscience
Max Planck Florida Institute for Neuroscience Miscellaneous Commercial ServicesCommercial Services Max Planck Florida Institute for Neuroscience provides research services. It offers its services for neurobiology, brain function, neural circuits, neurological disorders, synaptic networks and bio-imaging. The company was founded in 2008 and is headquartered in Jupiter, FL. | Commercial Services |
Advent International LLC
Advent International LLC Investment ManagersFinance Advent International LLC provides risk capital and investments. The company is headquartered in Boston, MA. | Finance |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Carrier Corp. manufactures air conditioning, heating, and refrigeration equipment. Its products include residential systems, commercial systems, transport refrigeration, and commercial refrigeration. The company was founded by Willis Haviland Carrier on July 17, 1902 and is headquartered in Jupiter, FL. | Producer Manufacturing |
- Borsa valori
- Insiders
- Jean-Pierre Garnier